Skip to main content

Study M632

Study name

Linghu T 2020

Title

A unique insight for energy metabolism disorders in depression based on chronic unpredictable mild stress rats using stable isotope-resolved metabolomics

Overall design

In this study, the stable isotope-resolved metabolomics (SIRM) technology was applied to the chronic unpredictable mild stress (CUMS) model of depression. Sprague-Dawley rats were divided into the following 2 groups (n = 10 in each group): (1) control group, and (2) CUMS group. The CUMS stress procedure lasted for 4 weeks. Hydrophilic metabolites and hydrophobic metabolites were extracted through different solvents and separated on the reverse-phase column (T3) and the normal-phase column (HILIC).

Study Type

Type1;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Sucrose preference test

Sample size

20

Tissue

Peripheral; Blood; Serum;

Platform

MS-based; LC-MS: Thermo DIONEX UltiMate 3000 high performance liquid chromatograph with Thermo Q Exactive HF Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientific, Inc., Germany);

PMID

32927418

DOI

10.1016/j.jpba.2020.113588

Citation

Linghu T, Gao Y, Li A, et al. A unique insight for energy metabolism disorders in depression based on chronic unpredictable mild stress rats using stable isotope-resolved metabolomics. J Pharm Biomed Anal. 2020;191:113588.

Metabolite

Glyceric acid;

Gamma-Aminobutyric acid;

L-Phenylalanine;

L-Tryptophan;

L-Leucine;

L-Glutamic acid;

L-Serine;

L-Threonine;

Arachidonic acid;

L-Methionine;

L-Lactic acid;

L-Asparagine;

L-Glutamine;

D-Fructose;

Uridine;

Pantothenic acid;

Taurocholic acid;

Phenylacetylglycine;

Pyruvic acid;

Gluconic acid;

Xanthosine;

Citrulline;

Ornithine;

Phosphorylcholine;

D-Galactose;

LysoPC(20:4/0:0);

LysoPE(0:0/18:2(9Z,12Z));

LysoPE(18:0/0:0);

1-heptadecanoyl-sn-glycero-3-Phosphocholine;

LysoPE(0:0/20:3(5Z,8Z,11Z));

LysoPC(20:5(5Z,8Z,11Z,14Z,17Z));

Indole;

Cholesterol sulfate;

Acetic anhydride;

2-Hydroxyvaleric acid;

Enadenine;

2-Aminoethylarsonic acid;

3-Oxotetradecanoic acid;

6-Keto-prostaglandin F1a;

trans-Hexadec-2-enoyl carnitine;

N-Stearoyl tyrosine;

Glycerophospho-N-palmitoyl ethanolamine;

LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0);

LysoPC(24:1(15Z)/0:0);

Coenzyme Q10;

PC(O-18:2(9Z,12Z)/18:2(9Z,12Z));

PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z));